Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

SPA agreement for phase III EOquin trials in noninvasive bladder cancer

March 15, 2007

Virax grants Transgene access to Co-X-Gene technology

March 15, 2007

Cell Therapeutics seeks SPA for pixantrone trial in indolent NHL

March 15, 2007

Phase Ib/II data on single agent ADH-1 presented

March 15, 2007

IRBM presents second-generation class I HDAC inhibitors at recent congress

March 15, 2007

Exelixis updates EXEL-2819 profile

March 15, 2007

Huya licenses ex-China rights to chidamide

March 15, 2007

Tykerb approved in combination with Xeloda for breast cancer

March 14, 2007

Antitumor activity seen in phase Ib/II trial of CTCE-9908

March 14, 2007

Alethia and Biosite to develop antibodies for use in ovarian cancer

March 14, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...